Myristoylated ZIP, pep2m, and scrambled peptide were acquired from Tocris Bioscience; prostaglandin E2 (PGE2) was obtained from Cayman Chemical Company; and nerve growth factor (NGF) was from R&D Systems. ZIP, pep2m and scrambled peptide stock solutions were prepared in sterile 0.9% saline and diluted from this stock solution for injection. PGE2 stock solutions were prepared in 100% ethanol and diluted in sterile saline for injection. Doses used in this study were based on our previous work (Asiedu et al., 2011 ) and other publications (Shi et al., 2001 (link), Pastalkova et al., 2006 (link), Shema et al., 2007 (link)). ZIP is not a selective inhibitor of aPKCs (Lee et al., 2013 (link), Volk et al., 2013 (link)). pep2m interferes with GluA2 binding to NSF and the effect of the peptide is absent in GluA2 KO mice, suggesting it is a specific tool peptide (Shi et al., 2001 (link)).
Free full text: Click here